Coverage and effectiveness of conditional cash transfer for people with drug resistant tuberculosis in Zimbabwe: A mixed methods study.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2022
Historique:
received: 13 08 2022
accepted: 28 11 2022
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

The End TB strategy recommends social protection to mitigate socio-economic impacts of tuberculosis. Zimbabwe started implementing a conditional cash transfer (CCT) programme for people on drug resistant tuberculosis (DR-TB) treatment in 2013. We aimed to determine the proportion of people receiving CCT and effectiveness of CCT in improving treatment outcomes, explore their experiences with registering for CCT and understand the impact of CCT from the perspective of beneficiaries. Data from 2014-2021 were extracted from TB registers and CCT payment records within the National TB Programme. Sixteen in-depth interviews were conducted with people who were completing treatment or had completed treatment within two months. Poisson regression, adjusted for province, year of treatment, age and sex was used to investigate associations between receiving CCT and successful treatment outcomes among people who were in DR-TB care for ≥3 months after treatment initiation. Qualitative data were analyzed using thematic analysis. A total of 481 people were included in the quantitative study. Of these, 53% (254/481) received CCT at some point during treatment. People who exited DR-TB care within three months were 73% less likely to receive CCT than those who did not (prevalence ratio (PR) = 0.27 [95%CI: 0.18-0.41]). Among those who were alive and in care three months after treatment initiation, CCT recipients were 32% more likely to have successful outcomes than those who did not (adjusted PR = 1.32, [95%CI: 1.00-1.75]). Qualitative results revealed lack of knowledge about availability of CCT among people with DR-TB and missed opportunities by healthcare providers to provide information about availability of CCT. Delays and inconsistencies in disbursements of CCT were frequent themes. CCT were associated with successful treatment outcomes. Improvements in coverage, timeliness and predictability of disbursements are recommended.

Identifiants

pubmed: 36962815
doi: 10.1371/journal.pgph.0001027
pii: PGPH-D-22-01252
pmc: PMC10021731
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0001027

Informations de copyright

Copyright: © 2022 Timire et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Soc Sci Med. 2015 Apr;130:42-50
pubmed: 25681713
BMC Infect Dis. 2016 Jun 21;16:307
pubmed: 27329161
PLoS One. 2020 Aug 10;15(8):e0237355
pubmed: 32776969
PLoS One. 2019 Feb 22;14(2):e0212617
pubmed: 30794615
BMJ Glob Health. 2019 Jan 24;4(1):e001029
pubmed: 30740248
Eur Respir J. 2014 Jun;43(6):1763-75
pubmed: 24525439
BMC Public Health. 2015 Aug 21;15:810
pubmed: 26293238
Glob Health Action. 2019;12(1):1633725
pubmed: 31328678
Trials. 2014 Jun 19;15:236
pubmed: 24947537
BMJ. 2009 Oct 26;339:b4248
pubmed: 19858174
Eur Respir J. 2020 Mar 20;55(3):
pubmed: 31862767
AIDS Behav. 2014 Oct;18 Suppl 5:S542-53
pubmed: 24710958
Sci Rep. 2022 Jan 11;12(1):558
pubmed: 35017604
BMC Public Health. 2018 Aug 22;18(1):1052
pubmed: 30134870
Cochrane Database Syst Rev. 2015 Sep 03;(9):CD007952
pubmed: 26333525
Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1129-1130
pubmed: 31718747
PLoS Med. 2019 Apr 30;16(4):e1002788
pubmed: 31039158
Infect Dis Poverty. 2018 Jan 12;7(1):3
pubmed: 29325589
Int J Tuberc Lung Dis. 2015 Dec;19(12):1513-9
pubmed: 26614194
BMC Public Health. 2012 Nov 14;12:980
pubmed: 23150901
Trials. 2013 May 28;14:154
pubmed: 23714270
Trop Med Int Health. 2018 Aug;23(8):870-878
pubmed: 29851223
PLoS Med. 2017 Nov 7;14(11):e1002418
pubmed: 29112693
BMC Health Serv Res. 2016 Jul 19;16:283
pubmed: 27430557
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):199-206
pubmed: 26884501
Trop Med Int Health. 2021 Oct;26(10):1248-1255
pubmed: 34192392

Auteurs

Collins Timire (C)

Department of Clinical Research, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
National TB Control Programme, Ministry of Health and Child Care, Harare, Zimbabwe.
Biomedical Research and Training Institute, The Health Research Unit, Harare, Zimbabwe.

Charles Sandy (C)

National TB Control Programme, Ministry of Health and Child Care, Harare, Zimbabwe.

Rashida A Ferrand (RA)

Department of Clinical Research, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
Biomedical Research and Training Institute, The Health Research Unit, Harare, Zimbabwe.

Regina Mubau (R)

National TB Control Programme, Ministry of Health and Child Care, Harare, Zimbabwe.

Peter Shiri (P)

National TB Control Programme, Ministry of Health and Child Care, Harare, Zimbabwe.

Obert Mbiriyawanda (O)

National TB Control Programme, Ministry of Health and Child Care, Harare, Zimbabwe.

Fredrick Mbiba (F)

Biomedical Research and Training Institute, The Health Research Unit, Harare, Zimbabwe.

Rein M G J Houben (RMGJ)

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Debora Pedrazzoli (D)

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Virginia Bond (V)

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Zambart, Lusaka, Zambia.

Nicola Foster (N)

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Katharina Kranzer (K)

Department of Clinical Research, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.
Biomedical Research and Training Institute, The Health Research Unit, Harare, Zimbabwe.
Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, Munich, Germany.

Classifications MeSH